Post Test: Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molecular ProfilingByJanuary 1st 2014
Biomarkers and Molecular Profiling in Non-Small Cell Lung Cancer: An Expanding Role and Its Managed Care ImplicationsByRobert T. Adamson, PharmD, FASHPDecember 31st 2013
Shifting Paradigms in Non-Small Cell Lung Cancer: An Evolving Therapeutic LandscapeByJonathan Riess, MD, MSDecember 30th 2013
